← Back to Search

Experimental: VID-KIDS Intervention Program Group for Postpartum Depression (VID-KIDS Trial)

N/A
Waitlist Available
Led By Nicole Letourneau
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Recruitment will be conducted through Calgary Public Health's immunization program. Public Health RNs routinely screen mothers for PPD during infants' vaccination clinic appointments using the Edinburgh Postnatal Depression Scale (EPDS) at 2, 4, and 6 months of age. EPDS scores>12 are indicative of probable major depression with postpartum onset and make a mother eligible for our study. Approximately 500 mothers per year (40/month) screen >12 on the EPDS. The investigators have agreed to support a part-time Calgary Public Health staff person to review screening records and contact potential participants to determine if they are willing to be contacted by a the VID-KIDS Project Manager for further information about the study. If mothers agree, then the VID-KIDS Project Manager will contact the mother to explain the study, further assess eligibility, and if appropriate conduct the informed consent procedure.
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 18 weeks
Awards & highlights
No Placebo-Only Group

VID-KIDS Trial Summary

This trial is investigating whether an in-person program designed to improve children's mental, emotional and behavioural health and development via parent-child relationship intervention can be delivered online.

Eligible Conditions
  • Postpartum Depression

VID-KIDS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

VID-KIDS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Nursing Child Assessment Satellite Training (NCAST) assessment scale will be used to evaluate Mother-Infant (M-I) interactions

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

VID-KIDS Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: VID-KIDS Intervention Program GroupExperimental Treatment1 Intervention
Experimental: VID-KIDS Intervention Program Group RN review photos of infant engagement/ disengagement cues. NCAST Teaching Activity, mothers asked to perform task advanced for infant's level, recorded. 1st-View, no feedback, mothers reveal infant cues. RN records infant/mother's response, later discussion. 2nd, RN and mother co-view interaction with time for replay/review parts of sensitivity and responsiveness. RN feedback: praising desired maternal behaviours; information on infant cues; maternal response to infant distress; and use of cognitive growth fostering language. 3rd, all concepts discussed in past views, use positive reinforcement to affirm aspects of sensitivity, useful feedback for areas of growth. Post-Debrief, RN and mother discuss interests of the mother. Mothers encouraged to note infants' engagement/disengagement cues.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VID-KIDS Intervention Program
2021
N/A
~20

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
768 Previous Clinical Trials
841,037 Total Patients Enrolled
2 Trials studying Postpartum Depression
400 Patients Enrolled for Postpartum Depression
Alberta Health servicesOTHER
155 Previous Clinical Trials
648,126 Total Patients Enrolled
1 Trials studying Postpartum Depression
400 Patients Enrolled for Postpartum Depression
Nicole LetourneauPrincipal InvestigatorUniversity of Calgary

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment to this research still open?

"Yes, the records on clinicaltrials.gov reveal that this trial is open for recruitment - it was initially advertised on March 15th 2021 and updated as recently as May 19th 2022. The study aims to enrol 100 participants at 2 sites."

Answered by AI

How many participants are currently enrolled in this experiment?

"Affirmative. According to clinicaltrials.gov, this experiment is still seeking participants; it was publicly announced on March 15th 2021 and revised most recently on May 19th 2022. The trial requires the recruitment of 100 individuals from 2 designated medical sites."

Answered by AI

Are there any eligibility requirements for participation in this experiment?

"This investigation is looking to enlist roughly 100 adults aged between 16 and 49, who have been diagnosed with depression postpartum."

Answered by AI

Is the enrollment criteria inclusive of geriatric individuals?

"Participants who hope to enrol in this clinical trial must be between 16 and 49 years old."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
University of Calgary
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
~5 spots leftby Feb 2025